The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Developing β‐secretase inhibitors for treatment of Alzheimer’s disease
Open accessAbstract
J. Neurochem. (2012) 120 (Suppl. 1), 71–83. β‐Secretase (memapsin 2; BACE‐1) is the first protease in the processing of amyloid precursor protein leading to the production of amyloid‐β (Aβ) in the brain. It is believed that high levels of brain Aβ are responsible for the pathogenesis of Alzheimer’s disease (AD). Therefore, β‐secretase is a major therapeutic target for the development of inhibitor drugs. During the past decade, steady progress has been made in the evolution of β‐secretase inhibitors toward better drug properties. Recent inhibitors are potent, selective and have been shown to penetrate the blood‐brain barrier to inhibit Aβ levels in the brains of experimental animals. Moreover, continuous administration of a β‐secretase inhibitor was shown to rescue age‐related cognitive decline in transgenic AD mice. A small number of β‐secretase inhibitors have also entered early phase clinical trials. These developments offer some optimism for the clinical development of a disease‐modifying drug for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedBACE1 is the major β-secretase for generation of Aβ peptides by neurons
Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L., & Wong, P. C. (2001) · Nature Neuroscience · doi:10.1038/85064 · Cited by 1,064
Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., et al. (2001) · Nature Neuroscience · doi:10.1038/85059 · Cited by 1,001
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 818
Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein
Lin, X., Koelsch, G., Wu, S., Downs, D., Dashti, A., & Tang, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1456 · Cited by 776
Self-citationThe Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease
Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G., & Ashe, K. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01858.2002 · Cited by 718
Structure of the Protease Domain of Memapsin 2 (β-Secretase) Complexed with Inhibitor
Hong, L., Koelsch, G., Lin, X., Wu, S., Terzyan, S., Ghosh, A. K., Zhang, X. C., & Tang, J. (2000) · Science · doi:10.1126/science.290.5489.150 · Cited by 711
Self-citationRoberds, S. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.12.1317 · Cited by 705
Ohno, M., Sametsky, E. A., Younkin, L. H., Oakley, H., Younkin, S. G., Citron, M., Vassar, R., & Disterhoft, J. F. (2004) · Neuron · doi:10.1016/s0896-6273(03)00810-9 · Cited by 549
Methods and Principles in Medicinal Chemistry
(2008) · Methods and principles in medicinal chemistry · doi:10.1002/series6138 · Cited by 514
Stachel, S. J., Coburn, C. A., Steele, T. G., Jones, K. G., Loutzenhiser, E. F., Gregro, A. R., Rajapakse, H. A., Lai, M.-T., Crouthamel, M.-C., Xu, M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049379g · Cited by 262
Structure-Based Design: Potent Inhibitors of Human Brain Memapsin 2 (β-Secretase)
Ghosh, A. K., Bilcer, G., Harwood, C., Kawahama, R., Shin, D., Hussain, K. A., Hong, L., Loy, J. A., Nguyen, C., Koelsch, G., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0101803 · Cited by 224
Self-citationDesign of Potent Inhibitors for Human Brain Memapsin 2 (β-Secretase)
Ghosh, A. K., Shin, D., Debbie Downs, Koelsch, G., Lin, X., Ermolieff, J., & Tang, J. (2000) · Journal of the American Chemical Society · doi:10.1021/ja000300g · Cited by 215
Self-citationHussain, I., Hawkins, J., Harrison, D., Hille, C., Wayne, G., Cutler, L., Buck, T., Walter, D., Demont, E., Howes, C., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04260.x · Cited by 201
Subsite Specificity of Memapsin 2 (β-Secretase): Implications for Inhibitor Design
Turner, R. T., Koelsch, G., Hong, L., Castenheira, P., Ghosh, A., & Tang, J. (2001) · Biochemistry · doi:10.1021/bi015546s · Cited by 185
Self-citationβ-Secretase as a Therapeutic Target for Alzheimer's Disease
Ghosh, A. K., Gemma, S., & Tang, J. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.007 · Cited by 183
Self-citationA Small Molecule Targeting the Multifactorial Nature of Alzheimer's Disease
Cavalli, A., Bolognesi, M. L., Capsoni, S., Andrisano, V., Bartolini, M., Margotti, E., Cattaneo, A., Recanatini, M., & Melchiorre, C. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700256 · Cited by 179
Baxter, E. W., Conway, K. A., Kennis, L. E. J., Bischoff, F., Mercken, M. H., Winter, H. L. D., Reynolds, C. H., Tounge, B. A., Luo, C., Scott, M. K., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0705408 · Cited by 156
Asai, M., Hattori, C., Iwata, N., Saido, T. C., Sasagawa, N., Szabó, B., Hashimoto, Y., Maruyama, K., Tanuma, S., Kiso, Y., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03576.x · Cited by 156
Fukumoto, H., Takahashi, H., Tarui, N., Matsui, J., Tomita, T., Hirode, M., Sagayama, M., Maeda, R., Kawamoto, M., Hirai, K., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2884-10.2010 · Cited by 144
Malamas, M. S., Erdei, J., Gunawan, I., Turner, J., Hu, Y., Wagner, E. J., Fan, K. Y., Chopra, R., Olland, A. M., Bard, J., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901414e · Cited by 132
Maillard, M. C., Hom, R. K., Benson, T. E., Moon, J. B., Mamo, S., Bienkowski, M. J., Tomasselli, A. G., Woods, D. D., Prince, D. B., Paddock, D. J., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061242y · Cited by 124
In vivo inhibition of Aβ production by memapsin 2 (β‐secretase) inhibitors
Chang, W., Koelsch, G., Wong, S., Downs, D., Da, H., Weerasena, V., Gordon, B., Devasamudram, T., Bilcer, G. M., Ghosh, A. K., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02452.x · Cited by 120
Self-citationSankaranarayanan, S., Holahan, M. A., Colussi, D. J., Crouthamel, M., Devanarayan, V., Ellis, J. D., Espeseth, A. S., Gates, A. T., Graham, S. L., Gregro, A. R., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143628 · Cited by 116
β‐Secretase inhibitor GRL‐8234 rescues age‐related cognitive decline in APP transgenic mice
Chang, W., Huang, X., Downs, D., Cirrito, J. R., Koelsch, G., Holtzman, D. M., Ghosh, A. K., & Tang, J. (2010) · The FASEB Journal · doi:10.1096/fj.10-167213 · Cited by 115
Self-citationAminoimidazoles as Potent and Selective Human β-Secretase (BACE1) Inhibitors
Malamas, M. S., Erdei, J., Gunawan, I., Barnes, K. D., Johnson, M., Hui, Y., Turner, J., Hu, Y., Wagner, E. J., Fan, K. Y., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9006752 · Cited by 114
Sankaranarayanan, S., Price, E. A., Wu, G., Crouthamel, M., Shi, X., Tugusheva, K., Tyler, K. X., Kahana, J. A., Ellis, J. D., Jin, L., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.130039 · Cited by 111
Zhu, Y., Xiao, K., Ma, L., Xiong, B., Fu, Y., Yu, H., Wang, W., Wang, X., Hu, D., Peng, H., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.12.067 · Cited by 109
Acylguanidines as Small-Molecule β-Secretase Inhibitors
Cole, D. C., Manas, E. S., Stock, J. R., Condon, J. S., Jennings, L. D., AULABAUGH, A. E., Chopra, R., Cowling, R. A., Ellingboe, J. W., Fan, K. Y., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0607451 · Cited by 105
BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild‐type mice2
Nishitomi, K., Sakaguchi, G., Horikoshi, Y., Gray, A. J., Maeda, M., Hirata‐Fukae, C., Becker, A. G., Hosono, M., Sakaguchi, I., Minami, S., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04178.x · Cited by 105
Kimura, T., Shuto, D., Hamada, Y., Igawa, N., Kasai, S., Liu, P., Hidaka, K., Hamada, T., Hayashi, Y., & Kiso, Y. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.090 · Cited by 105
Ghosh, A. K., Kumaragurubaran, N., Lin, H., Kulkarni, S. S., Xu, X., Miller, H. B., Reddy, D. S., Weerasena, V., Turner, R. T., Chang, W., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.12.028 · Cited by 96
Self-citationMacrocyclic Inhibitors of β-Secretase: Functional Activity in an Animal Model
Stachel, S. J., Coburn, C. A., Sankaranarayanan, S., Price, E. A., Pietrak, B., Huang, Q., Lineberger, J. E., Espeseth, A. S., Jin, L., Ellis, J. D., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060884i · Cited by 91
Ghosh, A. K., Kumaragurubaran, N., Lin, H., Kulkarni, S. S., Xu, X., Chang, W., Weerasena, V., Turner, R. T., Koelsch, G., Bilcer, G. M., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061338s · Cited by 85
Self-citationTurner, R. T., Lin, H., Koelsch, G., Ghosh, A. K., & Tang, J. (2004) · Biochemistry · doi:10.1021/bi048106k · Cited by 85
Self-citationDiscovery of Oxadiazoyl Tertiary Carbinamine Inhibitors of β-Secretase (BACE-1)
Rajapakse, H. A., Nantermet, P. G., Selnick, H. G., Munshi, S. K., McGaughey, G. B., Lindsley, S. R., Young, M. B., Lai, M., Espeseth, A. S., Shi, X., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm061046r · Cited by 84
Design and Synthesis of Hydroxyethylene-Based Peptidomimetic Inhibitors of Human β-Secretase
Hom, R. K., Gailunas, A. F., Mamo, S., Fang, L. Y., Tung, J. S., Walker, D., Davis, D. L., Thorsett, E. D., Jewett, N. E., Moon, J. B., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0304008 · Cited by 80
Ghosh, A. K., Devasamudram, T., Lin, H., DeZutter, C. B., Xu, X., Weerasena, V., Koelsch, G., Bilcer, G. M., & Tang, J. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.10.084 · Cited by 80
Self-citationPotent pyrrolidine- and piperidine-based BACE-1 inhibitors
Iserloh, U., Wu, Y., Cumming, J. N., Pan, J., Wang, L. Y., Stamford, A. W., Kennedy, M. E., Kuvelkar, R., Chen, X., Parker, E. M., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.116 · Cited by 80
Design and Synthesis of Statine-Based Cell-Permeable Peptidomimetic Inhibitors of Human β-Secretase
Hom, R. K., Fang, L. Y., Mamo, S., Tung, J. S., Guinn, A. C., Walker, D., Davis, D. L., Gailunas, A. F., Thorsett, E. D., Sinha, S., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm025619l · Cited by 78
γ-Secretase Inhibition and Modulation for Alzheimers Disease
Wolfe, M. S. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954767 · Cited by 77
Charrier, N., Clarke, B. P., Cutler, L., Demont, E. H., Dingwall, C., Dunsdon, R. M., East, P., Hawkins, J., Howes, C., Hussain, I., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800138h · Cited by 74
Discovery of an orally efficaceous 4-phenoxypyrrolidine-based BACE-1 inhibitor
Iserloh, U., Pan, J., Stamford, A. W., Kennedy, M. E., Zhang, Q., Zhang, L., Parker, E. M., McHugh, N. A., Favreau, L. V., Strickland, C., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.053 · Cited by 70
Stauffer, S. R., Stanton, M. G., Gregro, A. R., Steinbeiser, M. A., Shaffer, J. R., Nantermet, P. G., Barrow, J. C., Rittle, K. E., Collussi, D., Espeseth, A. S., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.051 · Cited by 64
Progress toward the discovery and development of efficacious BACE inhibitors.
Durham, T. B., & Shepherd, T. A. (2006) · PubMed · Cited by 64
Huang, W., Lv, D., Yu, H., Sheng, R., Kim, S. C., Wu, P., Luo, K., Li, J. X., & Hu, Y. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.06.042 · Cited by 61
Beswick, P., Charrier, N., Clarke, B. P., Demont, E. H., Dingwall, C., Dunsdon, R. M., Faller, A., Gleave, R. J., Hawkins, J., Hussain, I., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.12.020 · Cited by 59
Clarke, B. P., Demont, E. H., Dingwall, C., Dunsdon, R. M., Faller, A., Hawkins, J., Hussain, I., MacPherson, D. T., Maile, G., Matico, R., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.12.019 · Cited by 58
β-Secretase (BACE-1) inhibitory effect of biflavonoids
Sasaki, H., Miki, K., Kinoshita, K., Koyama, K., Juliawaty, L. D., Achmad, S. A., Hakim, E. H., Kaneda, M., & Takahashi, K. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.021 · Cited by 58
Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors
Cumming, J. N., Le, T. X., Babu, S. K. G., Carroll, C. D., Chen, X., Favreau, L. V., Gaspari, P. M., Guo, T., Hobbs, D., Huang, Y., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.04.050 · Cited by 58
Macrocyclic BACE-1 inhibitors acutely reduce Aβ in brain after po application
Lerchner, A. M., Machauer, R., Betschart, C., Veenstra, S. J., Rueeger, H., McCarthy, C., Tintelnot‐Blomley, M., Jaton, A.-L., Rabe, S., Desrayaud, S., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.092 · Cited by 58
Truong, A. P., Tóth, G., Probst, G. D., Sealy, J. M., Bowers, S., Wone, D. W. G., Dressen, D. B., Hom, R. K., Konradi, A. W., Sham, H. L., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.102 · Cited by 50
Design of potent inhibitors of human β-secretase. Part 2
Freskos, J. N., Fobian, Y. M., Benson, T. E., Moon, J. B., Bienkowski, M. J., Brown, D. L., Emmons, T. L., Heintz, R., LABORDE, A. L., McDonald, J. J., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.091 · Cited by 47
Piperazine sulfonamide BACE1 inhibitors: Design, synthesis, and in vivo characterization
Cumming, J. N., Babu, S., Huang, Y., Carroll, C. D., Chen, X., Favreau, L. V., Greenlee, W. J., Guo, T., Kennedy, M. E., Kuvelkar, R., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.050 · Cited by 47
Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors
Lindsley, S. R., Moore, K. P., Rajapakse, H. A., Selnick, H. G., Young, M. B., Zhu, H., Munshi, S. K., Kuo, L. C., McGaughey, G. B., Colussi, D. J., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.04.072 · Cited by 46
Potent and selective isophthalamide S2 hydroxyethylamine inhibitors of BACE1
Kortum, S. W., Benson, T. E., Bienkowski, M. J., Emmons, T. L., Prince, D. B., Paddock, D. J., Tomasselli, A. G., Moon, J. B., LABORDE, A. L., & TenBrink, R. E. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.096 · Cited by 46
Design of potent inhibitors of human β-secretase. Part 1
Freskos, J. N., Fobian, Y. M., Benson, T. E., Bienkowski, M. J., Brown, D. L., Emmons, T. L., Heintz, R., LABORDE, A. L., McDonald, J. J., Mischke, B. V., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.092 · Cited by 39
Sealy, J. M., Truong, A. P., Tso, L. S., Probst, G. D., Aquino, J., Hom, R. K., Jagodzinska, B. M., Dressen, D. B., Wone, D. W. G., Brogley, L., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.061 · Cited by 34
Design and Synthesis of Potent and Selective BACE-1 Inhibitors
Björklund, C., Oscarson, S., Benkestock, K., Borkakoti, N., Jansson, K., Lindberg, J., Vrang, L., Hallberg, A., Rosenquist, Å., & Samuelsson, B. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901168f · Cited by 33
Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening
Mok, N. Y., Chadwick, J., Kellett, K. A. B., Hooper, N. M., Johnson, A. P., & Fishwick, C. W. G. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.103 · Cited by 31
Hanessian, S., Shao, Z., Betschart, C., Rondeau, J., Neumann, U., & Tintelnot‐Blomley, M. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.139 · Cited by 27
α‐Naphthylaminopropan‐2‐ol Derivatives as BACE1 Inhibitors
Asso, V., Ghilardi, E., Bertini, S., Digiacomo, M., Granchi, C., Minutolo, F., Rapposelli, S., Bortolato, A., Moro, S., & Macchia, M. (2008) · ChemMedChem · doi:10.1002/cmdc.200800162 · Cited by 26
Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central core
Wångsell, F., Gustafsson, K. M., Kvarnström, I., Borkakoti, N., Edlund, M., Jansson, K., Lindberg, J., Hallberg, A., Rosenquist, Å., & Samuelsson, B. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.11.013 · Cited by 25
Xu, W., Chen, G., Zhu, W., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.111 · Cited by 23
Evolution of Tertiary Carbinamine BACE‐1 Inhibitors: Aβ Reduction in Rhesus CSF upon Oral Dosing
Nantermet, P. G., Rajapakse, H. A., Stanton, M., Stauffer, S. R., Barrow, J. C., Gregro, A. R., Moore, K. P., Steinbeiser, M. A., Swestock, J., Selnick, H. G., et al. (2008) · ChemMedChem · doi:10.1002/cmdc.200800308 · Cited by 21
Rapid P1 SAR of brain penetrant tertiary carbinamine derived BACE inhibitors
Zhu, H., Young, M. B., Nantermet, P. G., Graham, S. L., Colussi, D. J., Lai, M., Pietrak, B., Price, E. A., Sankaranarayanan, S., Shi, X., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.005 · Cited by 20
Wångsell, F., Nordeman, P., Sävmarker, J., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.11.042 · Cited by 19
Xu, W., Chen, G., Zhu, W., & Zuo, Z. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.140 · Cited by 17
Wångsell, F., Russo, F., Sävmarker, J., Rosenquist, Å., Samuelsson, B., & Larhed, M. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.065 · Cited by 13
Predicting memapsin 2 (β‐secretase) hydrolytic activity
Li, X., Huang, B., Zhang, X. C., Hartsuck, J. A., & Tang, J. (2010) · Protein Science · doi:10.1002/pro.502 · Cited by 13
Self-citationClinical Trials for Disease‐Modifying Drugs Such as BACE Inhibitors
Hsu, H. H. (2010) · Wiley eBooks · doi:10.1002/9780470594087.ch9 · Cited by 6
Cited by
A review on Alzheimer's disease pathophysiology and its management: an update
Kumar, A., Singh, A., & Ekavali (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.004 · Cited by 1,578
Therapeutics of Alzheimer's disease: Past, present and future
Anand, R., Gill, K. D., & Mahdi, A. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 747
Current and future treatments for Alzheimer's disease
Yiannopoulou, K. G., & Papageorgiou, S. G. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285612461679 · Cited by 677
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Molecular Recognition in Chemical and Biological Systems
Persch, E., Dumele, O., & Diederich, F. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201408487 · Cited by 654
Metadata
- Authors
- Ghosh, A. K., Brindisi, M., & Tang, J.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2011-11-28
- Volume
- 120
- Issue
- s1
- Pages
- 71-83
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1816679421
- Cited by
- 272
- References
- 71
- FWCI
- 17.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.